ATE334658T1 - Arzneimittel zur verabreichung an schleimhäute - Google Patents

Arzneimittel zur verabreichung an schleimhäute

Info

Publication number
ATE334658T1
ATE334658T1 AT01914018T AT01914018T ATE334658T1 AT E334658 T1 ATE334658 T1 AT E334658T1 AT 01914018 T AT01914018 T AT 01914018T AT 01914018 T AT01914018 T AT 01914018T AT E334658 T1 ATE334658 T1 AT E334658T1
Authority
AT
Austria
Prior art keywords
administration
mucous
measures
amount
medicinal products
Prior art date
Application number
AT01914018T
Other languages
English (en)
Inventor
Hazire Oya Alpar
James Edward Eyles
Ethel Diane Williamson
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0006770.2A external-priority patent/GB0006770D0/en
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of ATE334658T1 publication Critical patent/ATE334658T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01914018T 2000-03-22 2001-03-22 Arzneimittel zur verabreichung an schleimhäute ATE334658T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0006770.2A GB0006770D0 (en) 2000-03-22 2000-03-22 Vaccine composition
GBGB0101094.1A GB0101094D0 (en) 2000-03-22 2001-01-16 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE334658T1 true ATE334658T1 (de) 2006-08-15

Family

ID=26243921

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01914018T ATE334658T1 (de) 2000-03-22 2001-03-22 Arzneimittel zur verabreichung an schleimhäute

Country Status (8)

Country Link
US (1) US20050181063A1 (de)
EP (1) EP1265598B1 (de)
AT (1) ATE334658T1 (de)
AU (1) AU780182B2 (de)
CA (1) CA2399695A1 (de)
DE (1) DE60121925T2 (de)
ES (1) ES2272447T3 (de)
WO (1) WO2001070200A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE403436T1 (de) * 1999-03-24 2008-08-15 Secr Defence Polykationische karbohydrate als immunostimulierende mittel in impstoffen
AUPR011700A0 (en) 2000-09-14 2000-10-05 Austin Research Institute, The Composition comprising immunogenic virus sized particles (VSP)
GB0220257D0 (en) 2002-08-31 2002-10-09 Secr Defence Vaccine
GB0300885D0 (en) * 2003-01-15 2003-02-12 Secr Defence Pharmaceutical composition
GB0300881D0 (en) * 2003-01-15 2003-02-12 Secr Defence Therapeutic treatment
WO2017105512A1 (en) 2015-12-18 2017-06-22 Proinvet Innovations S.A. Formulations and methods for controlling the reproductive cycle and ovulation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740421A (en) * 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US5279936A (en) * 1989-12-22 1994-01-18 Syntex (U.S.A.) Inc. Method of separation employing magnetic particles and second medium
US5126147A (en) * 1990-02-08 1992-06-30 Biosearch, Inc. Sustained release dosage form
DE4004430A1 (de) * 1990-02-09 1991-08-14 Schering Ag Aus polyaldehyden aufgebaute kontrastmittel
US5292513A (en) * 1992-05-18 1994-03-08 Anthony G. Gristina Method for nonspecific cellular immune stimulation
EP0678035B9 (de) * 1993-01-08 2006-12-13 Csl Limited Impfstoffpräparate
US6913767B1 (en) * 1993-10-25 2005-07-05 Genentech, Inc. Compositions for microencapsulation of antigens for use as vaccines
US5643605A (en) * 1993-10-25 1997-07-01 Genentech, Inc. Methods and compositions for microencapsulation of adjuvants
US5902565A (en) * 1993-12-24 1999-05-11 Csl Limited Spray dried vaccine preparation comprising aluminium adsorbed immunogens
ES2185762T3 (es) * 1995-03-13 2003-05-01 Secr Defence Vacunas contra la peste.
US6428771B1 (en) * 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
GB9810126D0 (de) * 1998-05-13 1998-07-08 Glaxo Group Ltd
DK1126826T6 (en) * 1998-11-02 2019-06-24 Alkermes Pharma Ireland Ltd Multiparticulate modified release of methylphenidate
US20030171258A1 (en) * 1999-03-24 2003-09-11 Alpar Hazire Oya Particle based vaccine composition
ATE403436T1 (de) * 1999-03-24 2008-08-15 Secr Defence Polykationische karbohydrate als immunostimulierende mittel in impstoffen
US20020103165A1 (en) * 2000-02-29 2002-08-01 Alliance Pharmaceutical Corp., Engineered spray-dried lipid-based microparticles for cellular targeting
GB0300885D0 (en) * 2003-01-15 2003-02-12 Secr Defence Pharmaceutical composition

Also Published As

Publication number Publication date
EP1265598B1 (de) 2006-08-02
AU3940701A (en) 2001-10-03
AU780182B2 (en) 2005-03-03
ES2272447T3 (es) 2007-05-01
DE60121925D1 (de) 2006-09-14
US20050181063A1 (en) 2005-08-18
CA2399695A1 (en) 2001-09-27
EP1265598A1 (de) 2002-12-18
DE60121925T2 (de) 2007-03-01
WO2001070200A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
EP1389137A4 (de) Zusammensetzungen für die freisetzung von protein auf dem pulmonalen weg
ATE334663T1 (de) Arzneimittelzusammensetzung mit verzögerter wirkstoffabgabe
DE60121570D1 (de) Oral anzuwendende schnell zerfallende feste darreichungsformen
DK1660037T3 (da) Aripiprazol-injektionssuspension
BR0212475A (pt) Composições farmacêuticas
AR039744A1 (es) Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
ATE425744T1 (de) Pharmazeutische formulierungen mit verbesserter bioverfugbarkeit
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
ATE274344T1 (de) Pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung von phenytoin natrium
GB2237510B (en) Small particle drug compositions for nasal administration
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
ITBO20050388A1 (it) Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
BR9609663A (pt) Formulações para desprendimento controlado de medicamentos fracamente soluveis
DE69940735D1 (de) Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
KR20140100422A (ko) 백신 조성물
ATE359777T1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
ATE326264T1 (de) Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung
WO2003051394A3 (en) Calcium phosphate particles as mucosal adjuvants
SE0102036D0 (sv) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
ATE334658T1 (de) Arzneimittel zur verabreichung an schleimhäute
WO2005004860A3 (fr) Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
GB9906695D0 (en) Vaccine composition
SE0001916D0 (sv) Novel formulation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1265598

Country of ref document: EP

REN Ceased due to non-payment of the annual fee